1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing global prevalence and the periodic outbreak of infectious diseases
5.1.1.2. Elevations in IVD kits with improved sensitivity, speed, and patient compliance
5.1.1.3. Increasing R&D investments to launch new IVD products
5.1.2. Restraints
5.1.2.1. High expenses associated with IVD diagnostic tests
5.1.3. Opportunities
5.1.3.1. Advancements in genomics and proteomics
5.1.3.2. Developing tests for infectious disease in developing countries
5.1.4. Challenges
5.1.4.1. Unfavorable reimbursement scenario
5.2. Cumulative Impact of COVID-19

6. Infectious Diseases In-Vitro Diagnostics Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents
6.4. Software

7. Infectious Diseases In-Vitro Diagnostics Market, by Technology
7.1. Introduction
7.2. Immunochemistry
7.3. Microbiology
7.4. Molecular Diagnostics

8. Infectious Diseases In-Vitro Diagnostics Market, by Application
8.1. Introduction
8.2. Candida
8.3. Chlamydia
8.4. Clostridium difficile
8.5. CRE
8.6. Gastro-intestinal Panel Testing
8.7. Gonorrhea
8.8. Hepatitis
8.9. HIV
8.10. HPV
8.11. MRSA
8.12. Respiratory Virus
8.13. Streptococcus
8.14. TB and Drug-resistant TB
8.15. VRE

9. Infectious Diseases In-Vitro Diagnostics Market, by End-user
9.1. Introduction
9.2. Central Laboratories
9.3. Point of Care
9.4. Rapid Test Kit

10. Americas Infectious Diseases In-Vitro Diagnostics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Infectious Diseases In-Vitro Diagnostics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa Infectious Diseases In-Vitro Diagnostics Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Abbott Laboratories
14.2. Alere Inc.
14.3. Becton, Dickinson and Company
14.4. Bio-Rad Laboratories, Inc.
14.5. bioMérieux SA
14.6. Cepheid
14.7. DiaSorin S.p.A
14.8. F. Hoffmann La-Roche Ltd.
14.9. Genspeed Biotech GmbH
14.10. Grifols, S.A.
14.11. Hologic, Inc.
14.12. Illumina, Inc.
14.13. InBios International, Inc
14.14. Koninklijke Philips N.V.
14.15. Laboratory Corporation of America Holdings
14.16. Luminex Corporation
14.17. Merck KGaA
14.18. OraSure Technologies
14.19. Ortho Clinical Diagnostics
14.20. PerkinElmer, Inc
14.21. Qiagen N.V.
14.22. Quest Diagnostics
14.23. Quidel Corporation
14.24. Siemens Healthcare AG
14.25. Sysmex Corporation
14.26. Thermo Fisher Scientific

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2020 VS 2027 (%)
FIGURE 4. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2020 VS 2027 (USD BILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2027
FIGURE 6. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2027 (USD BILLION)
FIGURE 7. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 8. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2027 (USD BILLION)
FIGURE 9. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 10. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2027 (USD BILLION)
FIGURE 11. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 12. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY , 2020 VS 2027 (%)
FIGURE 13. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY , 2020 VS 2027 (USD BILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY , 2027
FIGURE 15. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, 2018-2027 (USD BILLION)
FIGURE 18. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2027 (USD BILLION)
FIGURE 20. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 21. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 22. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD BILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2027
FIGURE 24. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CANDIDA, 2018-2027 (USD BILLION)
FIGURE 25. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CANDIDA, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA, 2018-2027 (USD BILLION)
FIGURE 27. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLOSTRIDIUM DIFFICILE, 2018-2027 (USD BILLION)
FIGURE 29. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLOSTRIDIUM DIFFICILE, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CRE, 2018-2027 (USD BILLION)
FIGURE 31. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CRE, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY GASTRO-INTESTINAL PANEL TESTING, 2018-2027 (USD BILLION)
FIGURE 33. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY GASTRO-INTESTINAL PANEL TESTING, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 34. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY GONORRHEA, 2018-2027 (USD BILLION)
FIGURE 35. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY GONORRHEA, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 36. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEPATITIS, 2018-2027 (USD BILLION)
FIGURE 37. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEPATITIS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 38. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV, 2018-2027 (USD BILLION)
FIGURE 39. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 40. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY HPV, 2018-2027 (USD BILLION)
FIGURE 41. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY HPV, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 42. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY MRSA, 2018-2027 (USD BILLION)
FIGURE 43. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY MRSA, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 44. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY RESPIRATORY VIRUS, 2018-2027 (USD BILLION)
FIGURE 45. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY RESPIRATORY VIRUS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 46. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY STREPTOCOCCUS, 2018-2027 (USD BILLION)
FIGURE 47. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY STREPTOCOCCUS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 48. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY TB AND DRUG-RESISTANT TB, 2018-2027 (USD BILLION)
FIGURE 49. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY TB AND DRUG-RESISTANT TB, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 50. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY VRE, 2018-2027 (USD BILLION)
FIGURE 51. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY VRE, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 52. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY END-USER , 2020 VS 2027 (%)
FIGURE 53. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY END-USER , 2020 VS 2027 (USD BILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY END-USER , 2027
FIGURE 55. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CENTRAL LABORATORIES, 2018-2027 (USD BILLION)
FIGURE 56. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CENTRAL LABORATORIES, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 57. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2027 (USD BILLION)
FIGURE 58. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 59. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST KIT, 2018-2027 (USD BILLION)
FIGURE 60. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 61. AMERICAS INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. ARGENTINA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. BRAZIL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. CANADA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. MEXICO INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 66. UNITED STATES INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 67. ASIA-PACIFIC INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 68. AUSTRALIA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 69. CHINA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 70. INDIA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 71. INDONESIA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 72. JAPAN INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 73. MALAYSIA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 74. PHILIPPINES INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 75. SINGAPORE INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 76. SOUTH KOREA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 77. TAIWAN INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 78. THAILAND INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 79. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 80. FRANCE INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 81. GERMANY INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 82. ITALY INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 83. NETHERLANDS INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 84. QATAR INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 85. RUSSIA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 86. SAUDI ARABIA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 87. SOUTH AFRICA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 88. SPAIN INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 89. UNITED ARAB EMIRATES INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 90. UNITED KINGDOM INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 91. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 92. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 93. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY , 2018-2027 (USD BILLION)
TABLE 8. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CANDIDA, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA, BY REGION, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLOSTRIDIUM DIFFICILE, BY REGION, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CRE, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY GASTRO-INTESTINAL PANEL TESTING, BY REGION, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY GONORRHEA, BY REGION, 2018-2027 (USD BILLION)
TABLE 18. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2027 (USD BILLION)
TABLE 19. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV, BY REGION, 2018-2027 (USD BILLION)
TABLE 20. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY HPV, BY REGION, 2018-2027 (USD BILLION)
TABLE 21. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY MRSA, BY REGION, 2018-2027 (USD BILLION)
TABLE 22. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY RESPIRATORY VIRUS, BY REGION, 2018-2027 (USD BILLION)
TABLE 23. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY STREPTOCOCCUS, BY REGION, 2018-2027 (USD BILLION)
TABLE 24. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY TB AND DRUG-RESISTANT TB, BY REGION, 2018-2027 (USD BILLION)
TABLE 25. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY VRE, BY REGION, 2018-2027 (USD BILLION)
TABLE 26. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY END-USER , 2018-2027 (USD BILLION)
TABLE 27. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CENTRAL LABORATORIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 28. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2027 (USD BILLION)
TABLE 29. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2018-2027 (USD BILLION)
TABLE 30. AMERICAS INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 31. ARGENTINA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 32. BRAZIL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 33. CANADA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 34. MEXICO INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 35. UNITED STATES INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 36. ASIA-PACIFIC INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 37. AUSTRALIA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 38. CHINA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 39. INDIA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 40. INDONESIA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 41. JAPAN INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 42. MALAYSIA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 43. PHILIPPINES INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 44. SINGAPORE INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 45. SOUTH KOREA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 46. TAIWAN INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 47. THAILAND INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 49. FRANCE INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 50. GERMANY INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 51. ITALY INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 52. NETHERLANDS INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 53. QATAR INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 54. RUSSIA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 55. SAUDI ARABIA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 56. SOUTH AFRICA INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 57. SPAIN INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 58. UNITED ARAB EMIRATES INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 59. UNITED KINGDOM INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 60. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: SCORES
TABLE 61. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: BUSINESS STRATEGY
TABLE 62. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: PRODUCT SATISFACTION
TABLE 63. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: RANKING
TABLE 64. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 65. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: MERGER & ACQUISITION
TABLE 66. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 67. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 68. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: INVESTMENT & FUNDING
TABLE 69. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 70. GLOBAL INFECTIOUS DISEASES IN-VITRO DIAGNOSTICS MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Alere Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
bioMérieux SA
Cepheid
DiaSorin S.p.A
F. Hoffmann La-Roche Ltd.
Genspeed Biotech GmbH
Grifols, S.A.
Hologic, Inc.
Illumina, Inc.
InBios International, Inc
Koninklijke Philips N.V.
Laboratory Corporation of America Holdings
Luminex Corporation
Merck KGaA
OraSure Technologies
Ortho Clinical Diagnostics
PerkinElmer, Inc
Qiagen N.V.
Quest Diagnostics
Quidel Corporation
Siemens Healthcare AG
Sysmex Corporation
Thermo Fisher Scientific